Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension
- 1 February 2007
- journal article
- Published by Elsevier in Vascular Pharmacology
- Vol. 46 (2) , 144-151
- https://doi.org/10.1016/j.vph.2006.09.004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertensionJournal Of Hypertension, 2006
- NADPH Oxidase Inhibition Attenuates Oxidative Stress but Not Hypertension Produced by Chronic ET-1Hypertension, 2005
- Increased Renal Medullary H 2 O 2 Leads to HypertensionHypertension, 2003
- Contributions of 20-HETE to the Antihypertensive Effects of Tempol in Dahl Salt-Sensitive RatsHypertension, 2003
- A Mouse Model of Angiotensin II Slow Pressor ResponseJournal of the American Society of Nephrology, 2002
- Induction of Functional Bradykinin B 1 -Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor TreatmentCirculation, 2002
- Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II–Infused Hypertensive RatsHypertension, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- The B1 receptors for kinins.1998
- Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.1995